ELA
Envela Corporation
ELA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
NIO
NIO Inc.
NIO has the edge over ELA overall, supported by stronger modeled upside and lower modeled downside.
ELA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Healthy | |
| Strong |
ELA's revenue, profitability, cash flow and balance sheet are all currently healthy.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
ELA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $10.14 | -2.4% |
| Current | 12x | $10.39 | — |
| Fair | 18x | $15.50 | +49% |
| Forward | 19x | $10.39 | — |
| Expensive | 30x | $25.09 | +141% |
Historical ranges are pointers, not guarantees.
ELA's PE is in its cheap range at 12x. Analysts expect earnings to fall, which would put today's price at 19x next year's earnings, in its fair range.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
ELA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect ELA's earnings and revenue to decline, with profitability weakening.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over ELA on the outlook, with more favorable earnings and revenue expectations.
ELA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.56 | -35% |
| Q2 2026 | $0.85 | +150% |
| Q1 2026 | $0.80 | +176% |
| Q4 2025 | $0.56 | +115% |
| Q3 2025 | $0.41 | +64% |
| Q2 2025 | $0.34 | +36% |
| Q1 2025 | $0.29 | +16% |
| Q4 2024 | $0.26 | -3.7% |
| Q3 2024 | $0.25 | -42% |
ELA has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
ELA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $56.8M | +3.5% |
| Q1 2026 | $98.4M | +104% |
| Q4 2025 | $80.5M | +67% |
| Q3 2025 | $57.4M | +22% |
| Q2 2025 | $54.9M | +21% |
| Q1 2025 | $48.3M | +21% |
| Q4 2024 | $48.3M | +32% |
| Q3 2024 | $46.9M | +29% |
ELA has the edge over NIO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 9% | +3.1 points |
| Q1 2026 | 11% | +4.9 points |
| Q4 2025 | 9.4% | +5.4 points |
| Q3 2025 | 7.3% | +3 points |
| Q2 2025 | 5.9% | +1.7 points |
| Q1 2025 | 6.5% | +0.6 points |
| Q4 2024 | 3.9% | -0.4 points |
| Q3 2024 | 4.3% | -1.1 points |
ELA has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
ELA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5M | +137% |
| Q1 2026 | $20.6M | +2658% |
| Q4 2025 | -$3.7M | -215% |
| Q3 2025 | $2.2M | +51% |
| Q2 2025 | $2.1M | +$3.4M |
| Q1 2025 | $746.6K | -78% |
| Q4 2024 | $3.2M | +91% |
| Q3 2024 | $1.5M | +172% |
ELA has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
ELA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
ELA has more cash than debt.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ELA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.8 | Oversold |
| Stochastic | 1.6 | Oversold |
ELA's weekly RSI is 30 (oversold) and its Stochastic is 2 (oversold).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
ELA PE vs Consumer Cyclical Sector
| Metric | ELA | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 32% below |
| PE % | 20 | 47 | 27 pts below |
ELA is trading at 12x earnings, a 32% discount to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
ELA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.5 | 10% below |
| 20 week MA | $15.3 | 32% below |
| 50 week MA | $16.6 | 37% below |
| 100 week MA | $11.8 | 12% below |
| 200 week MA | $8.64 | 20% above |
ELA has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
ELA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.37 | $5.01 | +266% |
| 2021 | $5.01 | $4.10 | -18% |
| 2022 | $4.10 | $5.29 | +29% |
| 2023 | $5.29 | $4.86 | -8.1% |
| 2024 | $4.86 | $7.15 | +47% |
| 2025 | $7.15 | $12.5 | +75% |
| 2026 YTD | $12.5 | $10.4 | -17% |
ELA has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.